相关实验视频

Updated: Jan 15, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

糖尿病中的CALLY指数和高血压:一种复合的炎症-营养-免疫标志物

Jinxiang Peng^1,2, Jianjun Xiang³, Zhuang Chen⁴

¹Medical Department, Hubei Enshi College, Enshi, Hubei, China.

Science progress

|October 15, 2025

概括

在C反应性蛋白-白蛋白-淋巴细胞 (CALLY) 指数显示,与患有糖尿病的成年人高血压的患病率的反向关联. 较高的CALLY指数得分与较低的高血压率相关,表明其作为风险分层生物标志物的潜力.

科学领域:

生物标志物和健康结果
糖尿病研究研究糖尿病研究
心血管疾病流行病学

背景情况:

高血压是糖尿病成年人的严重并发症.
炎症,免疫状况和营养标志物都与糖尿病并发症有关.
对于糖尿病人群中高血压风险分层需要新的生物标志物.

研究的目的:

调查C反应性蛋白-白蛋白-淋巴细胞 (CALLY) 指数与高血压患病率之间的关联.
评估CALLY指数作为糖尿病成年人的潜在生物标志物.
利用国家调查数据,探索CALLY指数和高血压之间的关系.

主要方法:

使用国家健康和营养检查调查 (NHANES) 数据 (1999-2010年) 的横截面研究.
包括被诊断为糖尿病的成年参与者.
计算CALLY指数 (C-反应蛋白,白蛋白,淋巴细胞计数) 和后勤回归分析,调整为混因子. 使用受限立方线分析来评估非线性.

主要成果:

总共有4163名糖尿病成年人被分析.
在CALLY指数和高血压患病率之间发现了显著的反向关联.
较高的CALLY指数量与较低的高血压患病率 (OR=0.82,95% CI:0.71-0.94) 有关,具有非线性保护作用.

结论:

结合炎症,免疫和营养标记的CALLY指数与糖尿病成年人的高血压患病率有关.
卡利指数可能作为这种人群中高血压风险分层的生物标志物具有潜力.
由于研究的横截面性质,无法确定因果关系.

关键词:

卡利·卡利 (CALLY CALLY) 是一个著名的演员.糖尿病糖尿病患者糖尿病患者这种高血压,高血压.免疫力是一种免疫力.这是一种炎症炎症炎症炎症.营养营养营养营养

更多相关视频

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Hypertension I: Introduction

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...